No connection

Search Results

CCM vs LPCN

CCM
Concord Medical Services Holdings Limited
BEARISH
Price
$4.00
Market Cap
$17.4M
Sector
Healthcare
AI Confidence
95%
LPCN
Lipocine Inc.
BEARISH
Price
$2.38
Market Cap
$17.4M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
CCM
--
LPCN
--
Forward P/E
CCM
-26.67
LPCN
-1.92
P/B Ratio
CCM
-0.05
LPCN
1.01
P/S Ratio
CCM
0.05
LPCN
8.79
EV/EBITDA
CCM
-22.79
LPCN
-0.29

Profitability

Gross Margin
CCM
-11.44%
LPCN
100.0%
Operating Margin
CCM
-72.1%
LPCN
-219.65%
Profit Margin
CCM
-44.6%
LPCN
0.0%
ROE
CCM
-29.03%
LPCN
-54.28%
ROA
CCM
-4.48%
LPCN
-32.81%

Growth

Revenue Growth
CCM
-8.3%
LPCN
-67.2%
Earnings Growth
CCM
--
LPCN
--

Financial Health

Debt/Equity
CCM
2.22
LPCN
0.03
Current Ratio
CCM
0.42
LPCN
6.68
Quick Ratio
CCM
0.1
LPCN
6.36

Dividends

Dividend Yield
CCM
--
LPCN
--
Payout Ratio
CCM
0.0%
LPCN
0.0%

AI Verdict

CCM BEARISH

CCM exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis. The company suffers from negative gross margins (-11.44%), meaning it loses money on every unit of service provided before operating expenses are even considered. With a Price-to-Book ratio of -0.05, the company has negative shareholder equity, and a Quick Ratio of 0.10 indicates an inability to meet short-term obligations. Combined with declining revenue (-8.30% YoY) and a 5-year price collapse of 89%, the fundamental outlook is highly precarious.

Strengths
Extremely low Price-to-Sales ratio (0.05)
Recent short-term price recovery (+9.6% over 1 month)
Positive Q/Q EPS growth (+60.4%) though still negative in absolute terms
Risks
Negative Gross Margins indicating a fundamentally broken business model
Severe liquidity risk with a Current Ratio of 0.42 and Quick Ratio of 0.10
Negative Book Value (Price/Book -0.05) suggesting insolvency
LPCN BEARISH

LPCN exhibits critical fundamental weakness, highlighted by a Piotroski F-Score of 0/9, indicating severe deterioration across all financial health dimensions. While the company maintains a strong liquidity position with a current ratio of 6.68 and negligible debt, these are offset by a catastrophic 67.2% year-over-year revenue collapse and an operating margin of -219.65%. The technical trend is entirely bearish (0/100), and the stock has lost over 90% of its value over five years. Despite a lone analyst's optimistic $11.00 target, the data suggests a company in operational distress.

Strengths
Very low debt-to-equity ratio (0.03)
Strong short-term liquidity (Current Ratio 6.68)
Trading near book value (P/B 1.01)
Risks
Severe revenue decline (-67.2% YoY)
Critical financial health score (Piotroski 0/9)
Extreme negative operating margins (-219.65%)

Compare Another Pair

CCM vs LPCN: Head-to-Head Comparison

This page compares Concord Medical Services Holdings Limited (CCM) and Lipocine Inc. (LPCN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile